DrugPatentWatch Database Preview
BOTOX Drug Profile
Email this page to a colleague
» See Plans and PricingSummary for Tradename: BOTOX
| Patents: | 46 |
| Applicants: | 1 |
| BLAs: | 1 |
| Suppliers: see list | 1 |
| Drug Prices: | Drug price information for BOTOX |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for BOTOX |
Recent Litigation for BOTOX
Identify key patents and potential future biosimilar entrants
District Court Litigation
| Case Name | Date |
|---|---|
| In re: Aoki | 2013-07-30 |
PTAB Litigation
| Petitioner | Date |
|---|---|
| 2017-02-21 |
Pharmacology for BOTOX
| Mechanism of Action | Acetylcholine Release Inhibitors |
Company Disclosures: US Patents for BOTOX
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Allergan | BOTOX | onabotulinumtoxina | VIAL; SINGLE-USE | 103000 | 001 | 1991-12-09 | Start Trial | The Regents of the University of Colorado (Boulder, CO) | 2017-07-15 | RX | company | |
| Allergan | BOTOX | onabotulinumtoxina | VIAL; SINGLE-USE | 103000 | 001 | 1991-12-09 | Start Trial | Allergan, Inc. (Irvine, CA) | 2013-12-28 | RX | company | |
| Allergan | BOTOX | onabotulinumtoxina | VIAL; SINGLE-USE | 103000 | 001 | 1991-12-09 | Start Trial | Allergan, Inc. (Irvine, CA) | 2013-12-28 | RX | company | |
| Allergan | BOTOX | onabotulinumtoxina | VIAL; SINGLE-USE | 103000 | 001 | 1991-12-09 | Start Trial | Allergan, Inc. (Irvine, CA) | 2013-12-28 | RX | company | |
| Allergan | BOTOX | onabotulinumtoxina | VIAL; SINGLE-USE | 103000 | 001 | 1991-12-09 | Start Trial | The Regents of the University of Colorado (Boulder, CO) | 2017-07-15 | RX | company | |
| Allergan | BOTOX | onabotulinumtoxina | VIAL; SINGLE-USE | 103000 | 001 | 1991-12-09 | Start Trial | The Regents of the University of Colorado (Boulder, CO) | 2017-07-15 | RX | company | |
| Allergan | BOTOX | onabotulinumtoxina | VIAL; SINGLE-USE | 103000 | 001 | 1991-12-09 | Start Trial | The Regents of the University of Colorado (Denver, CO) | 2017-07-15 | RX | company | |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
Patent Text Search: US Patents for BOTOX
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Allergan | BOTOX | onabotulinumtoxina | VIAL; SINGLE-USE | 103000 | 001 | 1991-12-09 | Start Trial | SIO2 MEDICAL PRODUCTS, INC. (Auburn, AL) | 2033-03-11 | RX | search | |
| Allergan | BOTOX | onabotulinumtoxina | VIAL; SINGLE-USE | 103000 | 001 | 1991-12-09 | Start Trial | NANOMED SKINCARE, INC. (Cupertino, CA) | 2039-02-26 | RX | search | |
| Allergan | BOTOX | onabotulinumtoxina | VIAL; SINGLE-USE | 103000 | 001 | 1991-12-09 | Start Trial | Allergan, Inc. (Irvine, CA) | 2039-02-26 | RX | search | |
| Allergan | BOTOX | onabotulinumtoxina | VIAL; SINGLE-USE | 103000 | 001 | 1991-12-09 | Start Trial | 2034-03-16 | RX | search | ||
| Allergan | BOTOX | onabotulinumtoxina | VIAL; SINGLE-USE | 103000 | 001 | 1991-12-09 | Start Trial | BRIGHAM YOUNG UNIVERSITY (Provo, UT) | 2036-03-11 | RX | search | |
| Allergan | BOTOX | onabotulinumtoxina | VIAL; SINGLE-USE | 103000 | 001 | 1991-12-09 | Start Trial | URO-1, INC. (Winston-Salem, NC) | 2039-05-16 | RX | search | |
| Allergan | BOTOX | onabotulinumtoxina | VIAL; SINGLE-USE | 103000 | 001 | 1991-12-09 | Start Trial | 2035-12-21 | RX | search | ||
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
International Patents for BOTOX
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Australia | 2011201107 | Start Trial |
| Canada | 2505930 | Start Trial |
| Germany | 69833059 | Start Trial |
| World Intellectual Property Organization (WIPO) | 2015148688 | Start Trial |
| Japan | 5005753 | Start Trial |
| South Korea | 20060126793 | Start Trial |
| Canada | 3036632 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for BOTOX
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|
| 132008901655480 | Italy | Start Trial | PRODUCT NAME: NEUROTOSSINA DI CLOSTRIDIUM BOTULINUM DI TIPO A (150 KD) PRIVA DI PROTEINE COMPLESSATE(XEOMIN); AUTHORISATION NUMBER(S) AND DATE(S): 838, 20080409;57093.00.00, 20050531 |
| C300564 | Netherlands | Start Trial | PRODUCT NAME: BOTULINUM TOXINE; NAT. REGISTRATION NO/DATE: RVG 32957RVG 17379RVG 32958 2012270627; FIRST REGISTRATION: NL 25449 20110822 |
| CR 2013 00041 | Denmark | Start Trial | PRODUCT NAME: BOTULINUM TOXIN, HERUNDER BOTULINUM TOXIN A; NAT. REG. NO/DATE: 43623, 31350, 46039 (DK) 20130219; FIRST REG. NO/DATE: FI 25162,15424, 28146 20130116 |
| 300563 | Netherlands | Start Trial | DETAILS ASSIGNMENT: VERANDERING VAN EIGENAAR(S), OVERDRACHT |
| SPC/GB12/053 | United Kingdom | Start Trial | PRODUCT NAME: BOTULINUM TOXIN; REGISTERED: UK PL 00426/0074-0110 20120924; UK PL 00426/0118-0030 20120924; UK PL 00426/0119-0012 20120924; REASON FOR LAPSE: SURRENDERED |
| C300654 | Netherlands | Start Trial | PRODUCT NAME: BOTULINUM TOXINE, TYPE A; NAT. REGISTRATION NO/DATE: RVG 17379RVG 32957RVG 32958 20131029; FIRST REGISTRATION: |
| 122008000043 | Germany | Start Trial | PRODUCT NAME: CLOSTRIDIUM BOTULINUM NEUROTOXIN TYP A (150KD), FREI VON KOMPLEXPROTEINEN; REGISTRATION NO/DATE: 57093.00.00 20050531 |
| >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
